WHAT IS THE RISK CLASSIFICATION OF THE t(11;14) in MM? This has been a long-debated question and probably asked in the wrong way. I have always had a special interest in the t(11;14) and want to tell a story and how it relates to venetoclax. #mmsm #ASH19 1/x

Lucky to have my poster next to @BioBenBarwick poster which definitely brought in a lot of foot traffic #IMS23

Thank you #IMS23 for giving us a chance to present our SNP rs9344 and t(11;14) FISH testing studies. Great to catch up with colleagues in person, initiate new collaborative opportunities and learn about advances in myeloma treatment. Mayo Myeloma

A great opportunity at University of Minnesota

single-cell folks, what's the cell annotation tool do you recommend for immune cells and tumor cells? singleR? Seurat based label transfer? or sc-best-practices.org/cellular_struc… I still find myself using marker genes manually quite often

Our goal is to improve FISH reporting for myeloma. If you are a myeloma clinician, please consider this survey. Your responses will be helpful as we propose solutions for standardization and improve reporting clarity. Thank you! Mayo Myeloma

Excited to see our new paper entitled "Genomic Classification and Individualized Prognosis in Multiple Myeloma" out on Journal of Clinical Oncology! A fantastic collaboration between Sylvester Comprehensive Cancer Center, University of Miami, Memorial Sloan Kettering Cancer Center, NYU Langone Health, Moffitt Cancer Center, Heidelberg Myeloma and many others!! #mmsm (1/x)

Grand challenge of moving cancer whole-genome sequencing into the clinic. Comment on the largest whole-genome sequencing study- a myriad of actionable alterations and logistical,technical and economic challenges #precisionmedicine Nature Medicine bit.ly/3NY4yWo

Thank you to those who have completed the myeloma FISH survey! We are so grateful. If you haven’t yet completed the survey, we ask you to please consider making your voice heard. Your responses are so valuable. #MMSM Rahul Banerjee, MD, FACP

We are eager to hear from the community clinicians!

pubmed.ncbi.nlm.nih.gov/38744822/

The MMRF Immune Atlas team describes immune cells & clinical outcomes in myeloma. Emory, Beth Israel, WUSTL, MSSM, Mayo & MMRF profiled >1.1 million marrow cells from CoMMpass patients. Preprint at biorxiv.org/content/10.110… has details. #myeloma

Visualize genomic data with ease using gggenomes, an R package that extends ggplot2 to handle and display genomic information intuitively. Whether you’re comparing genomes, analyzing features, or showcasing synteny, gggenomes provides the tools you need to turn complex genomic

We’re hiring! Postdoc in Computational Genomics at Institute of Genetics and Cancer Focus: myeloma genome, structural variants, heterochromatin, multiomics Deadline: 9 July 2025, 23:59 GMT Apply here: elxw.fa.em3.oraclecloud.com/hcmUI/Candidat… #myeloma #postdoc #genomics #bioinformatics #epigenetics #codeandkilts

We will also be providing recommendations to other labs on how to perform and interpret to meet the IMS/IMWG definition with a publication led by Linda B. Baughn in Blood Cancer Journal shortly. Stay tuned.

Standardizing FISH testing in myeloma is critical to reduce lab to lab variability and misinterpretation. We propose guidelines for FISH panel design and reporting to align with the new IMS/IMWG risk stratification. Cancer Genomics Consortium (CGC) Mayo Myeloma